[ Citizens United for Research in Epilepsy - Cure Epilepsy Award | Research Funding ]
Event details
| Date | 11.01.2021 |
| Category | Call for proposal |
Aim: CURE funds research that has the potential to truly transform and save lives. This investigator-initiated grant program seeks to push the envelope and accelerate promising research leading to disease-modifying breakthroughs for people living with epilepsy. CURE Epilepsy prioritizes highly innovative, risky, paradigm-shifting projects that address CURE Epilepsy’s mission to cure epilepsy, affirming our core belief that the only acceptable final goal is “no seizures, no side-effects.”
The following priority areas reflect CURE Epilepsy’s focus on advances that have the potential to truly transform and save lives. Prevention, disease modification and elimination are critical goals and consistent with our mission.
Funding: max. $250,000
Duration: 2 years
Eligibility: This award is available to both established and early career investigators. Postdoctoral fellows may not apply for this award.
How to Apply: All applicants must submit a Letter of Intent (LOI). The LOI should clearly and succinctly outline the specific aims and include a brief description of the justification and research plan according to the guidelines in the RFA. LOIs and full proposals (by invitation) must be submitted through proposalCENTRAL. To begin an application, applicants will need to create a professional profile, if one does not already exist. If EPFL will serve as your host institution, please use the following institution name in proposalCENTRAL: Ecole Polytechnique Fédérale de Lausanne EPFL. After the LOI has been evaluated, selected applicants will be invited to submit a full proposal. At this stage, a signature from an institutional representative will be required; for this, please contact the Research Office.
Deadline, Letter of Intent: 11-January-2021 (9:00 PM ET)
Further information
The following priority areas reflect CURE Epilepsy’s focus on advances that have the potential to truly transform and save lives. Prevention, disease modification and elimination are critical goals and consistent with our mission.
- Transformative research to enhance our understanding of the cellular, molecular, genetic and systems-level mechanisms that lead to any of the epilepsies, facilitating the continued investigation of disease-modifying or preventative strategies
- Innovative approaches that can prevent, modify and/or arrest the development of acquired epilepsy. Examples include epilepsy that develops after stroke, tumor, traumatic brain injury or infection, including febrile infection-related epilepsy syndrome (FIRES) as well new-onset refractory status-epilepticus (NORSE)
- Research that will inform the development of novel therapies to prevent onset or halt the progression of the severe pediatric epilepsies
- Research focused on new, effective treatments for the >30% of the epilepsy population who are pharmacoresistant
- Novel research that furthers our understanding of the causes and ultimate elimination of SUDEP
- Translational, clinical, and clinically informed basic research that will facilitate understanding of the cellular-, molecular-, and systems-level mechanisms that underlie the relationships between sleep and epilepsy
Funding: max. $250,000
Duration: 2 years
Eligibility: This award is available to both established and early career investigators. Postdoctoral fellows may not apply for this award.
How to Apply: All applicants must submit a Letter of Intent (LOI). The LOI should clearly and succinctly outline the specific aims and include a brief description of the justification and research plan according to the guidelines in the RFA. LOIs and full proposals (by invitation) must be submitted through proposalCENTRAL. To begin an application, applicants will need to create a professional profile, if one does not already exist. If EPFL will serve as your host institution, please use the following institution name in proposalCENTRAL: Ecole Polytechnique Fédérale de Lausanne EPFL. After the LOI has been evaluated, selected applicants will be invited to submit a full proposal. At this stage, a signature from an institutional representative will be required; for this, please contact the Research Office.
Deadline, Letter of Intent: 11-January-2021 (9:00 PM ET)
Further information
- More information about the program is available here
- The Request for Applications (RFA) can be found here
- The application portal can be found here
- For any other questions, please contact the Research Office
Practical information
- General public
- Free